Companies: 48,687 Total Market Cap: 127143185345817.95

Takeda Pharmaceutical Company Limited

NYSE: TAK
Healthcare Drug Manufacturers - Specialty & Generic
Rank #452
Market Cap 46.27 B
Volume 1.39 M
Price 15.32
Change (%) 1.90%
Country or region Japan Japan

Takeda Pharmaceutical Company Limited's latest marketcap:

46.27 B

As of May 3, 2025, Takeda Pharmaceutical Company Limited's market capitalization has reached $46.27 B. According to our data, Takeda Pharmaceutical Company Limited is the 452th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 46.27 B
Revenue (ttm) 29.12 B
Net Income (ttm) 1.32 B
Shares Out 1.59 B
EPS (ttm) 0.83
Forward PE 0.00
Ex-Dividend Date March 31, 2025
Earnings Date May 8, 2025
Market Cap Chart
Data Updated: May 3, 2025

Takeda Pharmaceutical Company Limited's yearly market capitalization.

Takeda Pharmaceutical Company Limited has seen its market value drop from $81.14 B to $47.65 B since 2010, representing a total decrease of 41.27% and an annual compound decline rate (CAGR) of 3.65%.
Date Market Cap Change (%)
April 25, 2025 $47.65 B 13.11%
December 31, 2024 $42.13 B -5.91%
December 29, 2023 $44.78 B -7.43%
December 30, 2022 $48.37 B 13.5%
December 31, 2021 $42.62 B -24.84%
December 31, 2020 $56.70 B -8.18%
December 31, 2019 $61.76 B 134.31%
December 31, 2018 $26.36 B -65.5%
March 30, 2017 $76.41 B 18.26%
December 30, 2016 $64.61 B -22.54%
December 31, 2015 $83.40 B 20.68%
December 31, 2014 $69.11 B -9.9%
December 31, 2013 $76.71 B 3.69%
December 31, 2012 $73.97 B 0.68%
December 30, 2011 $73.47 B -9.45%
December 31, 2010 $81.14 B

Company Profile

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited is a global leader in the research, development, manufacturing, and marketing of pharmaceutical products. Headquartered in Tokyo, Japan, the company has been at the forefront of healthcare innovation since its founding in 1781.

Core Therapeutic Areas

Takeda specializes in delivering advanced treatments across several key medical fields, including:

  • Gastroenterology
  • Rare Diseases
  • Plasma-Derived Therapies
  • Immunology
  • Oncology
  • Neuroscience

Key Product Brands

Takeda offers a diverse portfolio of pharmaceutical products under well-known brands, such as:

  • Entyvio
  • Adcetris
  • Vyvanse/Elvanse
  • Trintellix
  • QDENGA
  • Alunbrig
  • Ninlaro
  • Livtencity
  • Takhzyro
  • Gammagard Liquid/Kiovig

Strategic Collaborations & Partnerships

Takeda actively engages in research collaborations and licensing agreements with leading biotech and pharmaceutical organizations, including:

  • BioMarin
  • GlaxoSmithKline
  • Neurocrine Biosciences
  • Denali Therapeutics
  • Mirum Pharmaceuticals
  • Teva Pharmaceutical Industries
  • Arrowhead Pharmaceuticals
  • Poseida Therapeutics

With a strong commitment to innovation, Takeda continues to expand its global footprint and deliver transformative healthcare solutions worldwide.

Frequently Asked Questions

As of May 3, 2025, Takeda Pharmaceutical Company Limited (including the parent company, if applicable) has an estimated market capitalization of $46.27 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Takeda Pharmaceutical Company Limited global market capitalization ranking is approximately 452 as of May 3, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Japan
Founded 1781
IPO Date n/a
Employees 49,281
CEO Christophe Weber
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Address 1-1, Nihonbashi-Honcho 2-chome, Chuo-ku
Tokyo, 103-8668
Japan
People Also Watch
GOOGL
164.03 2.29%
META
597.02 2.29%
HKG-0700
62.92 2.29%
SPOT
644 2.29%